Queensland Centre for Mental Health Research: the first 17 years

References

• Whiteford H A, Stedman T J, Welham J, Csernansky J G, Pond S M. Placebo-controlled, double-blind study of the effects of proglumide in the treatment of schizophrenia. Journal of Clinical Psychopharmacology 1992; 12: 337–340
   PubMed Web of Science ®Google Scholar
• Stedman T J, Whiteford H A, Eyles D, Welham J L, Pond S M. Effects of nifedipine on psychosis and tardive dyskinesia in schizophrenic patients. Journal of Clinical Psychopharmacology 1991; 11: 43–47
   PubMed Web of Science ®Google Scholar
• Whiteford H A, Stedman T J, McGrath J J, Welham J, Pond S. An open-label study of famotidine as a treatment for schizophrenia. Journal of Psychiatry and Neuroscience 1995; 20: 239–240
   PubMed Web of Science ®Google Scholar
• Hayes R L, McGrath J J. Cognitive rehabilitation for people with schizophrenia and related conditions. The Cochrane Database of Systematic Reviews 2000; CD000968
   Google Scholar
• Leucht S, Kissling W, McGrath J. Lithium for schizophrenia revisited: a systematic review and meta-analysis of randomized controlled trials. Journal of Clinical Psychiatry 2004; 65: 177–186
   PubMed Web of Science ®Google Scholar
• Leucht S, McGrath J, White P, Kissling W. Carbamazepine for schizophrenia and schizoaffective psychoses. The Cochrane Database of Systematic Reviews 2002; CD001258
   Google Scholar
• McGrath J J, Soares K V. Benzodiazepines for neurolepticinduced tardive dyskinesia. The Cochrane Database of Systematic Reviews 2000; CD000205
   Google Scholar
• McGrath J J, Soares K V. Miscellaneous treatments for neuroleptic-induced tardive dyskinesia. The Cochrane Database of Systematic Reviews 2000; CD000208
   Google Scholar
• McGrath J J, Soares K V. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia. The Cochrane Database of Systematic Reviews 2000; CD000459
   Google Scholar
• Soares K V, McGrath J J. Diltiazem, nifedipine, nimodipine or verapamil for neuroleptic-induced tardive dyskinesia. The Cochrane Database of Systematic Reviews 2000; CD000206
   Google Scholar
• Soares K V, McGrath J J. Vitamin E for neuroleptic-induced tardive dyskinesia. The Cochrane Database of Systematic Reviews 2000; CD000209
   Google Scholar
• Soares K V, McGrath J J. Calcium channel blockers for neuroleptic-induced tardive dyskinesia. The Cochrane Database of Systematic Reviews 2001; CD000206
   Google Scholar
• Soares K V, McGrath J J. Vitamin E for neuroleptic-induced tardive dyskinesia. The Cochrane Database of Systematic Reviews 2001; CD000209
   Google Scholar
• Soares K V, McGrath J J, Deeks J J. Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia. The Cochrane Database of Systematic Reviews 2001; CD000203
   Google Scholar
• Tammenmaa I A, McGrath J J, Sailas E, Soares-Weiser K. Cholinergic medication for neuroleptic-induced tardive dyskinesia. The Cochrane Database of Systematic Reviews 2002; CD000207
   Google Scholar
• Davies G, Welham J, Chant D C, Torrey E F, McGrath J. Season of birth effect and latitude: a systematic review and metaanalysis of Northern Hemisphere studies. Schizophrenia Bulletin 2003; 29: 587–593
   PubMed Web of Science ®Google Scholar
• McGrath J, Saha S, Welham J, El Saadi O, MacCauley C, Chant D. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Medicine 2004; 2: 13
   PubMed Web of Science ®Google Scholar
• McGrath J J, Welham J L. Season of birth and schizophrenia: a systematic review and meta-analysis of data from the Southern Hemisphere. Schizophrenia Research 1999; 35: 237–242
   PubMed Web of Science ®Google Scholar
• Barkla J, Byrne L, Hearle J, Plant K, Jenner L, McGrath J. Pregnancy in women with psychotic disorders. Archives of Women's Mental Health 2000; 3: 23–26
   Google Scholar
• Byrne L, Hearle J, Plant K, Barkla J, Jenner L, McGrath J. Working with parents with a serious mental illness: what do service providers think?. Australian Social Work 2000; 53: 21–26
   Google Scholar
• Hearle J, McGrath J. Mothers with schizophrenia. Women and schizophrenia, J McGrath. Camridge University Press, Cambridge 2000; 79–94
   Google Scholar
• Hearle J, Plant K, Jenner L, Barkla J, McGrath J. A survey of contact with offspring and assistance with child care among parents with psychotic disorders. Psychiatric Services 1999; 50: 1354–1356
   PubMed Web of Science ®Google Scholar
• McGrath J J, Hearle J, Jenner L, Plant K, Drummond A, Barkla J M. The fertility and fecundity of patients with psychosis. Acta Psychiatrica Scandinavica 1999; 99: 441–446
   PubMed Web of Science ®Google Scholar
• McLean D, Hearle J, McGrath J. Are services for families with a mentally ill parent adequate?. Parental psychiatric disorder: distressed parents and their families, M V Seeman. Cambridge University Press, Cambridge 2004; 333–334
   Google Scholar
• Stedman T. Approaches to measuring quality of life and their relevance to mental health. Australian and New Zealand Journal of Psychiatry 1996; 30: 731–740
   PubMed Web of Science ®Google Scholar
• Stedman T, Yellowlees P, Drake S, Chant D, Clarke R, Chapple B. The perceived utility of six selected measures of consumer outcomes proposed for routine use in Australian mental health services. Australian and New Zealand Journal of Psychiatry 2000; 34: 842–849
   PubMed Web of Science ®Google Scholar
• Welham J, Haire M, Mercer D, Stedman T. A gap approach to exploring quality of life in mental health. Quality of Life Research 2001; 10: 421–429
   PubMed Web of Science ®Google Scholar
• McGrath J, Welham J, Pemberton M. Month of birth, hemisphere of birth and schizophrenia. British Journal of Psychiatry 1995; 167: 783–785
   PubMed Web of Science ®Google Scholar
• Welham J L, Davies G, Auliciems A, McGrath J. Climate and geography and the epidemiology of schizophrenia. International Journal of Mental Health 2000; 29: 70–100
   Web of Science ®Google Scholar
• McGrath J J, Pemberton M R, Welham J L, Murray R M. Schizophrenia and the influenza epidemics of 1954, 1957 and 1959: a southern hemisphere study. Schizophrenia Research 1994; 14: 1–8
   PubMed Web of Science ®Google Scholar
• Welham J, McLachlan G, Davies G, McGrath J. Heterogeneity in schizophrenia; mixture modelling of age-at-first- admission, gender and diagnosis. Acta Psychiatrica Scandinavica 2000; 101: 312–317
   PubMed Web of Science ®Google Scholar
• Welham J L, Pemberton M R, McGrath J J. Incorporating lag effects in register-based age-of-onset distributions in schizophrenia. Schizophrenia Research 1996; 20: 125–132
   PubMed Web of Science ®Google Scholar
• Jablensky A, McGrath J, Herrman H, et al. Psychotic disorders in urban areas: an overview of the Study on Low Prevalence Disorders. Australian and New Zealand Journal of Psychiatry 2000; 34: 221–236
   PubMed Web of Science ®Google Scholar
• Jablensky A, McGrath J, Herrman H, et al. People living with psychotic illness: an Australian study 1997–98. Cmmonwealth of Australia, Canberra 1999
   Google Scholar
• El-Saadi O, Pedersen C B, McNeil T F, et al. Paternal and maternal age as risk factors for psychosis: findings from Denmark, Sweden and Australia. Schizophrenia Research 2004; 67: 227–236
   PubMed Web of Science ®Google Scholar
• McGrath J, El-Saadi O, Cardy S, Chapple B, Chant D, Mowry B. Urban birth and migrant status as risk factors for psychosis: an Australian case–control study. Social Psychiatry and Psychiatric Epidemiology 2001; 36: 533–536
   PubMed Web of Science ®Google Scholar
• McGrath J, El-Saadi O, Grim V, et al. Minor physical anomalies and quantitative measures of the head and face in patients with psychosis. Archives of General Psychiatry 2002; 59: 458–464
   PubMed Web of Science ®Google Scholar
• Saha S, Loesch D, Chant D, et al. Directional and fluctuating asymmetry in finger and a-b ridge counts in psychosis: a case–control study. BMC Psychiatry 2003; 3: 3
   PubMed Web of Science ®Google Scholar
• McGrath J. Hypothesis: is low prenatal vitamin D a riskmodifying factor for schizophrenia? Schizophrenia Research. 1999; 40: 173–177
   Google Scholar
• McGrath J. Does ‘imprinting’ with low prenatal vitamin D contribute to the risk of various adult disorders? Medical Hypotheses. 2001; 56: 367–371
   Google Scholar
• McGrath J, Eyles D, Mowry B, Yolken R, Buka S L. Low maternal vitamin D as a risk factor for schizophrenia: a pilot study using banked sera. Schizophrenia Research 2003; 63: 73–78
   PubMed Web of Science ®Google Scholar
• McGrath J, Saari K, Hakko H, et al. Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth-cohort study. Schizophrenia Research 2004; 67: 237–245
   PubMed Web of Science ®Google Scholar
• McGrath J J, Feron F P, Burne T H, Mackay-Sim A, Eyles D W. The neurodevelopmental hypothesis of schizophrenia: a review of recent developments. Annals of Medicine 2003; 35: 86–93
   PubMed Web of Science ®Google Scholar
• McGrath J J, Murray R M. Risk factors for schizophrenia: from conception to birth. Schizophrenia, S R Hirsch. Blackwells, Oxford 2003; 232–250
   Google Scholar
• Feron F, Perry C, Hirning M H, McGrath J, Mackay-Sim A. Altered adhesion, proliferation and death in neural cultures from adults with schizophrenia. Schizophrenia Research 1999; 40: 211–218
   PubMed Web of Science ®Google Scholar
• Feron F, Perry C, McGrath J J, Mackay-Sim A. New techniques for biopsy and culture of human olfactory epithelial neurons. Archives of Otolaryngology – Head and Neck Surgery 1998; 124: 861–866
   PubMed Web of Science ®Google Scholar
• Eyles D, Brown J, Mackay-Sim A, McGrath J, Feron F. Vitamin D3 and brain development. Neuroscience 2003; 118: 641–653
   PubMed Web of Science ®Google Scholar
• Brown J, Bianco J I, McGrath J J, Eyles D W. 1,25-Dihydroxyvitamin D(3) induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neuroscience Letter 2003; 343: 139–143
   PubMed Web of Science ®Google Scholar
• Burkert R, McGrath J, Eyles D W. Vitamin D receptor expression in the embryonic rat brain. Neuroscience Research Communications 2003; 33: 63–71
   Google Scholar
• Burne T H, Becker A, Brown J, Eyles D W, Mackay-Sim A, McGrath J J. Transient prenatal Vitamin D deficiency is associated with hyperlocomotion in adult rats. Behavioural Brain Research 2004; 154: 549–555
   PubMed Web of Science ®Google Scholar
• Burne T H, Feron F, Brown J, Eyles D W, McGrath J J, Mackay-Sim A. Combined prenatal and chronic postnatal vitamin D deficiency in rats impairs prepulse inhibition of acoustic startle. Physiology Behaviour 2004; 81: 651–655
   PubMed Web of Science ®Google Scholar
• Levinson D F, Mowry B J. Genetics of schizophrenia. Genetic influences on neural and behavioural functions, T Joh. CRC Press, New York 2000; 47–82
   Google Scholar
• Mowry B J, Nancarrow D J. Molecular genetics of schizophrenia. Clinical and Experimental Pharmacology and Physiology 2001; 28: 66–69
   PubMed Web of Science ®Google Scholar
• Levinson D F, Mowry B J. Defining the schizophrenia spectrum: issues for genetic linkage studies. Schizophrenia Bulletin 1991; 17: 491–514
   PubMed Web of Science ®Google Scholar
• Levinson D F, Mowry B J, Escamilla M A, Faraone S V. The Lifetime Dimensions of Psychosis Scale (LDPS): description and interrater reliability. Schizophrenia Bulletin 2002; 28: 683–695
   PubMed Web of Science ®Google Scholar
• Levinson D F, Mahtani M M, Nancarrow D J, et al. Genome scan of schizophrenia. American Journal of Psychiatry 1998; 155: 741–750
   PubMed Web of Science ®Google Scholar
• Mowry B J, Ewen K R, Nancarrow D J, et al. Second stage of a genome scan of schizophrenia: study of five positive regions in an expanded sample. American Journal of Medical Genetics 2000; 96: 864–869
   PubMed Web of Science ®Google Scholar
• Lewis C M, Levinson D F, Wise L H, et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. American Journal of Human Genetics 2003; 73: 34–48
   PubMed Web of Science ®Google Scholar
• Chant D, Mowry B, McGrath J. Assessing the co-segregation of disorders within pedigrees: a comparison of two methods. Australasian Epidemiologist 2002; 1: 29–33
   Google Scholar
• Ewen K R, Bahlo M, Treloar S A, et al. Identification and analysis of error types in high-throughput genotyping. American Journal of Human Genetics 2000; 67: 727–736
   PubMed Web of Science ®Google Scholar
• Nancarrow D J, Mowry B J. Affected-only multiplex pedigree analysis of GAW10 problem 2. Genetics Epidemiology 1997; 14: 1029–1034
   PubMed Web of Science ®Google Scholar
• Handoko H Y, Nancarrow D J, Hayward N K, et al. Tumor necrosis factor haplotype analysis amongst schizophrenia probands from four distinct populations in the Asia–Pacific region. American Journal of Medical Genetics 2003; 121B: 1–6
   PubMed Web of Science ®Google Scholar
• Mowry B, Nancarrow D, Lennon D, et al. Schizophrenia susceptibility and chromosome 6p24-22. Nature Genetics 1995; 11: 233–234
   PubMed Web of Science ®Google Scholar
• Nancarrow D J, Levinson D F, Taylor J M, et al. No support for linkage to the bipolar regions on chromosomes 4p, 18p, or 18q in 43 schizophrenia pedigrees. American Journal of Medical Genetics 2000; 96: 224–227
   PubMed Web of Science ®Google Scholar
• Gill M, Vallada H, Collier D, et al. A combined analysis of D22S278 marker alleles in affected sib-pairs: support for a susceptibility locus for schizophrenia at chromosome 22q12. Schizophrenia Collaborative Linkage Group (Chromosome 22). American Journal of Medical Genetics 1996; 67: 40–45
   PubMed Web of Science ®Google Scholar
• SLCG. Additional support for schizophrenia linkage on chromosomes 6 and 8: a multicenter study. Schizophrenia Linkage Collaborative Group for Chromosomes 3, 6 and 8. American Journal of Medical Genetics 1996; 67: 580–594
   PubMed Web of Science ®Google Scholar
• Dann J, De Lisi L E, Devoto M, et al. A linkage study of schizophrenia to markers within Xp11 near the MAOB gene. Psychiatry Research 1997; 70: 131–143
   PubMed Web of Science ®Google Scholar
• Levinson D F, Holmans P A, Laurent C, et al. No major schizophrenia locus detected on chromosome 1q in a large multicenter sample. Science 2002; 296: 739–741
   PubMed Web of Science ®Google Scholar
• Mowry B J, Holmans P A, Pulver A E, et al. Multicenter linkage study of schizophrenia loci on chromosome 22q. Molecular Psychiatry 2004; 9: 784–795
   PubMed Web of Science ®Google Scholar
• Martinez M, Goldin L R, Cao Q, et al. Follow-up study on a susceptibility locus for schizophrenia on chromosome 6q. American Journal of Medical Genetics 1999; 88: 337–343
   PubMed Web of Science ®Google Scholar
• Duan J, Martinez M, Sanders A R, et al. Polymorphisms in trace amine receptor 4 (TRAR4) are associated with susceptibility for schizophrenia on chromosome 6q23.2. American Journal of Human Genetics 2004; 75: 624–638
   PubMed Web of Science ®Google Scholar
• Duan J, Sanders A R, Molen J E, et al. Polymorphisms in the 5_-untranslated region of the human serotonin receptor 1B (HTR1B) gene affect gene expression. Molecular Psychiatry 2003; 8: 901–910
   PubMed Web of Science ®Google Scholar
• Sanders A R, Cao Q, Taylor J, et al. Genetic diversity of the human serotonin receptor 1B (HTR1B) gene. Genomics 2001; 72: 1–14
   PubMed Web of Science ®Google Scholar
• Barrett R B, Loa P, Jerah E, Nancarrow D, Chant D, Mowry B J. Rates of treated schizophrenia and its clinical and cultural features in the population isolate of the Iban of Sarawak: a tri-diagnostic approach. Psychological Medicine 2005; 35: 281–293
   PubMed Web of Science ®Google Scholar
• Whiteford H. Can research influence mental health policy? Australian and New Zealand Journal of Psychiatry. 2001; 35: 428–434
   Google Scholar
• Townsend C, Whiteford H, Baingana F, et al. A mental health policy template: domains and elements for mental health policy formulation. International Review of Psychiatry 2004; 16: 18–23
   PubMed Web of Science ®Google Scholar
• Whiteford H, Buckingham W, Manderscheid R. Australia's National Mental Health Strategy. British Journal of Psychiatry 2002; 180: 210–215
   PubMed Web of Science ®Google Scholar
• Doessel D, Scheurer R, Chant D, Whiteford H. Australia's National Mental Health Strategy and deinstitutionalisation: some empirical results. Australian and New Zealand Journal of Psychiatry in press
   Google Scholar
• Burgess P, Pirkis J, Buckingham W, Burns J, Eagar K, Eckstein G. Adult mental health needs and expenditure in Australia. Social Psychiatry and Psychiatric Epidemiology 2005; 39: 55–66
   Web of Science ®Google Scholar
• Waghorn G, Chant D, White P, Whiteford H. Delineating disability, labour force participation and employment restrictions among persons with psychosis. Acta Psychiatrica Scandinavica 2004; 109: 279–288
   PubMed Web of Science ®Google Scholar
• Waghorn G, Chant D, White P, Whiteford H. Disability, employment and work performance among persons with ICD-10 anxiety disorders. Australian and New Zealand Journal of Psychiatry in press
   Google Scholar
• Waghorn G, Chant D C, Whiteford H. Clinical and non-clinical predictors of vocational recovery for Australians with psychotic disorders. Journal of Rehabilitation 2002; 68: 40–51
   Web of Science ®Google Scholar